New FDA Guidance Documents Resource Available
Keeping up with new FDA guidance documents can be challenging. The FDA regularly publishes new draft and final guidance covering topics ranging from drug development and manufacturing to diagnostics, biologics, cell and gene therapy, medical devices, and regulatory policy. Finding relevant documents, understanding their status, and tracking updates often requires searching through hundreds of individual pages.
To make this process easier, we have created a comprehensive FDA Guidance Document Resource that brings the latest guidance documents together in one searchable location.
The new resource includes:
- Guidance document title
- Publication date
- FDA office that issued the guidance
- Topic area
- Guidance status, including draft or final
- Direct link to the original FDA guidance document
- FDA description of the guidance
- Docket number, when applicable
The library is designed to help researchers, regulatory professionals, quality teams, manufacturers, and product developers quickly identify guidance relevant to their programs without spending valuable time searching multiple FDA pages.
Updated as new guidance becomes available
The resource is continuously updated as FDA publishes new guidance documents, making it a convenient place to monitor changes that may affect development, manufacturing, testing, quality systems, and regulatory submissions.
Whether you are developing a new therapeutic, validating an analytical method, manufacturing a biologic, or preparing a regulatory submission, staying informed about the latest FDA recommendations can help support better planning and decision-making throughout the product lifecycle.
Browse the FDA guidance library
We invite you to explore the new FDA Guidance Document Resource and use it as a reference for identifying the latest FDA guidance across a broad range of therapeutic areas and regulatory topics.
As new draft and final guidances are released, they will be added to the library, providing a single location to stay current with FDA’s evolving recommendations for industry.
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!